<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resource table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td valign="top">Gene (Homo sapiens)</td><td valign="top">CD95L</td><td valign="top">NA</td><td valign="top">NM_000639</td><td valign="top"/></tr><tr><td valign="top">Gene (H. sapiens)</td><td valign="top">CD95</td><td valign="top">NA</td><td valign="top">NM_000043</td><td valign="top"/></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">NB7</td><td valign="top">PMID: 10802708</td><td valign="top">BRENDA Tissue and <break/>Enzyme Source <break/>Ontology: BTO_0003439; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_8824">CVCL_8824</ext-link></td><td valign="top">Human neuroblastoma derived from <break/>autonomic ganglia; carries a deletion <break/>in both alleles of CASP8</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8</td><td valign="top">PMID: 4016745; <break/>PMID: 25984343</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_8878">CVCL_8878</ext-link>; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_8878">CVCL_8878</ext-link></td><td valign="top">Human high grade ovarian <break/>serous adenocarcinoma; derived <break/>from parent Hey cells (RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0297">CVCL_0297</ext-link>)</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8 &#916;shL3</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">Pool of three HeyA8 cell clones with <break/>homozygous 41 nucleotide deletion <break/>of the shL3 target site <break/>(chr1:172,665,726&#8211;172,655,766; Human <break/>Dec. 2013 GRCh38/hg38 assembly) <break/>produced using CRISPR/Cas9 technology.</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8 &#916;siL3</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">Pool of three HeyA8 cell clones with <break/>homozygous 64 nucleotide deletion of <break/>the siL3 target site <break/>(chr1:172,669,178&#8211;172,659,241; Human <break/>Dec. 2013 GRCh38/hg38 assembly) <break/>produced using CRISPR/Cas9 technology.</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8 &#916;shR6; shR6 <break/>k.o. clone #11</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">HeyA8 cell clone #11 with homozygous <break/>227 nucleotide deletion of the shR6 <break/>target site (chr10:89,008,920&#8211;89,009,146; <break/>Human Dec. 2013 GRCh38/hg38 <break/>assembly) produced using <break/>CRISPR/Cas9 technology; verified <break/>homozygous CD95 protein knockout</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8 shR6 k.o. <break/>clone #1</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">HeyA8 cell clone #1 with a small deletion <break/>and the 227 nucleotide deletion of the <break/>shR6 target site and an insertion of the <break/>pMJ920 plasmid fragment in CD95 <break/>produced using CRISPR/Cas9 <break/>technology; verified homozygous <break/>CD95 protein knockout</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8 shR6 k.o. <break/>clone #2</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">HeyA8 cell clone #2 with a 227 <break/>nucleotide deletion of the shR6 <break/>target site (chr10:89,008,920&#8211;89,009,146; <break/>Human Dec. 2013 GRCh38/hg38 assembly) <break/>in one allele and an insertion of the <break/>pSCB plasmid fragment in the other <break/>in CD95 produced using <break/>CRISPR/Cas9 technology; verified <break/>homozygous CD695 protein knockout</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">MCF-7</td><td valign="top">ATCC</td><td valign="top">ATCC: HTB-22; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0031">CVCL_0031</ext-link></td><td valign="top">Human adenocarcinoma of the mammary <break/>gland, breast; derived from metastatic <break/>site: pleural effusion</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HCT116</td><td valign="top">Korean Collection for <break/>Type Cultures (KCTC)</td><td valign="top">KCTC: cat#HC19023; <break/>ATCC: CCL_247; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0291">CVCL_0291</ext-link></td><td valign="top">Human colorectal carcinoma</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">Drosha<sup>-/-</sup>; Drosha<sup>-/-</sup> <break/>clone #40</td><td valign="top">Korean Collection for <break/>Type Cultures (KCTC); <break/>PMID: 26976605</td><td valign="top">KCTC: cat#HC19020</td><td valign="top">HCT116 clone #40 with homozygous <break/>protein knockout of Drosha; knockout <break/>achieved using CRISPR/Cas9 which <break/>resulted in a single nucleotide insertion <break/>in one allele and a 26 nuceotide <break/>deletion in the other</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">Dicer<sup>-/-</sup>; Dicer<sup>-/-</sup> <break/>clone #43</td><td valign="top">Korean Collection for <break/>Type Cultures (KCTC); <break/>PMID: 26976606</td><td valign="top">KCTC: cat#HC19023</td><td valign="top">HCT116 clone #43 with homozygous <break/>protein knockout of Dicer; knockout <break/>achieved using CRISPR/Cas9 which <break/>resulted in a three nucleotide <break/>insertion and 14 nucleotide deltion <break/>in one allele and a 35 nuceotide <break/>deletion in the other</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">Dicer<sup>-/-</sup>; Dicer<sup>-/-</sup> <break/>clone #45</td><td valign="top">Korean Collection for <break/>Type Cultures (KCTC); <break/>PMID: 26976607</td><td valign="top">KCTC: cat#HC19024</td><td valign="top">HCT116 clone #45 with homozygous <break/>protein knockout of Dicer; knockout <break/>achieved using CRISPR/Cas9 which <break/>resulted in a 53 nucleotide deltion <break/>in one allele and a 28 nuceotide <break/>deletion in the other</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">293T</td><td valign="top">ATCC</td><td valign="top">ATCC: CRL-3216; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0063">CVCL_0063</ext-link></td><td valign="top">Derived from HEK293 cells <break/>(ATCC: CRL-1573); express large T <break/>antigen; used for packaging viruses</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">293T &#916;shL3</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">Pool of three 293T cell clones with <break/>homozygous 41 nucleotide deletion <break/>of the shL3 target site <break/>(chr1:172,665,726&#8211;172,655,766; <break/>Human Dec. 2013 GRCh38/hg38 <break/>assembly) produced using <break/>CRISPR/Cas9 technology.</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">Phoenix-AMPHO</td><td valign="top">ATCC</td><td valign="top">ATCC: CRL-3213; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_H716">CVCL_H716</ext-link></td><td valign="top">Second generation retrovirus <break/>producer cell line</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-&#946;-actin antibody <break/>(mouse monoclonal)</td><td valign="top">Santa Cruz</td><td valign="top">Santa Cruz: <break/>cat#sc-47778; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_626632">AB_626632</ext-link></td><td valign="top">1:2000; for western blot; <break/>primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD95L <break/>(Mouse IgG1 <break/>monoclonal)</td><td valign="top">BD Biosciences</td><td valign="top">BD Biosciences: <break/>cat#556387; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396402">AB_396402</ext-link></td><td valign="top">1:500; for western blot; <break/>primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD95 <break/>(rabbit polyclonal)</td><td valign="top">Santa Cruz</td><td valign="top">Santa Cruz: <break/>cat#sc-715; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2100386">AB_2100386</ext-link></td><td valign="top">1:1000; for western blot; <break/>primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human AGO2 <break/>(rabbit monoclonal)</td><td valign="top">Abcam</td><td valign="top">Abcam: cat#AB186733; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2713978">AB_2713978</ext-link></td><td valign="top">1:2000; for western blot; <break/>primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human Drosha <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cell Signaling: <break/>cat#3364; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2238644">AB_2238644</ext-link></td><td valign="top">1:1000; for western blot; <break/>primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human Dicer <break/>(rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cell Signaling: <break/>cat#3363; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2093073">AB_2093073</ext-link></td><td valign="top">1:1000; for western blot; <break/>primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-rabbit, <break/>IgG-HRP</td><td valign="top">Southern Biotech</td><td valign="top">Southern Biotech: <break/>cat#SB-4030&#8211;05; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2687483">AB_2687483</ext-link></td><td valign="top">1:5000; for western blot; <break/>secondary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-rabbit, <break/>IgG-HRP</td><td valign="top">Cell Signaling</td><td valign="top">Cell Signaling: <break/>cat#7074; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2099233">AB_2099233</ext-link></td><td valign="top">1:2000; for western blot; <break/>secondary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-mouse; <break/>IgG1-HRP</td><td valign="top">Southern Biotech</td><td valign="top">Southern BioTech: <break/>cat#1070&#8211;05; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2650509">AB_2650509</ext-link></td><td valign="top">1:5000; for western blot; <break/>secondary Ab</td></tr><tr><td valign="top">Isotype control</td><td valign="top">FITC-mouse IgG1, <break/>&#954; isotype control</td><td valign="top">BD Biosciences</td><td valign="top">BD Biosciences: <break/>cat#551954; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394297">AB_394297</ext-link></td><td valign="top">4 uL used for 1&#160;&#215;&#160;10^6 cells; <break/>for flow cytometry</td></tr><tr><td valign="top">Antibody</td><td valign="top">FITC-mouse <break/>anti-Human CD95</td><td valign="top">BD Biosciences</td><td valign="top">BD Biosciences: <break/>cat#556640; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396506">AB_396506</ext-link></td><td valign="top">4 uL used for 1&#160;&#215;&#160;10^6 cells; <break/>for flow cytometry</td></tr><tr><td valign="top">Recombinant protein <break/>reagent</td><td valign="top">sCD95L (S2)</td><td valign="top">PMID: 14504390</td><td valign="top">NA</td><td valign="top">Soluble form of human CD95L <break/>(amino acids 137&#8211;281); <break/>recombinant protein</td></tr><tr><td valign="top">Recombinant protein <break/>reagent</td><td valign="top">LzCD95L</td><td valign="top">PMID: 14504390</td><td valign="top">NA</td><td valign="top">Leucine zipper tagged CD95L; <break/>recombinant protein</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">propidium iodide</td><td valign="top">Sigma-Aldrich</td><td valign="top">Sigma-Aldrich: <break/>cat#P4864</td><td valign="top">Used for subG1 flow cytometry analysis</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">puromycin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Sigma-Aldrich: <break/>cat#P9620</td><td valign="top">Used for selection of cells expressing <break/>puromycin resistance cassettes</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">G418</td><td valign="top">Affymetrix</td><td valign="top">Affymetrix: <break/>cat#11379</td><td valign="top">Used for selection of cells <break/>expressing G418 resistance cassette</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">venus-CD95L <break/>sensor (plasmid)</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">Modified CD510B-1 lentiviral vector <break/>(PMID: 25366259) was used as backbone; <break/>vector expresses a venus-human <break/>CD95L conjugate mRNA that can be <break/>used to monitor RNAi activity of <break/>si/shRNAs targeting CD95L using <break/>venus fluorescence.</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">venus-CD95 <break/>sensor (plasmid)</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">Modified CD510B-1 lentiviral vector <break/>(PMID: 25366259) was used as backbone; <break/>vector expresses a venus-human CD95 <break/>conjugate mRNA that can be used <break/>to monitor RNAi activity of <break/>si/shRNAs targeting CD95 <break/>using venus fluorescence.</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pLenti-GIII-CMV- <break/>RFP-2A-Puro <break/>vector; pLenti</td><td valign="top">ABM Inc</td><td valign="top">NA</td><td valign="top">pLenti control empty lentiviral vector; <break/>carries an RFP-2a-puromycin <break/>resistance cassette</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pLNCX2</td><td valign="top">Clontech</td><td valign="top">Clontech: <break/>cat#631503</td><td valign="top">pLNCX2 control empty <break/>retroviral vector; <break/>carries a neomycin <break/>resistance cassette</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pTIP</td><td valign="top">PMID: 24656822</td><td valign="top">NA</td><td valign="top">Lentivirus used for doxycycline- <break/>induced expression of shRNAs; <break/>contains puromycin resistance <break/>cassette; modified from the <break/>original backbone which <break/>contained a GFP cassette instead <break/>of a puromycin cassette <break/>(PMID: 17311008); original <break/>backbone from the Rossi lab.</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pLenti-CD95L-WT</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector <break/>that expresses human wild type <break/>CD95L cDNA (NM_000639.2); <break/>used to express wt human <break/>CD95L upon infection <break/>with lentiviral particles</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pLenti-CD95L- <break/>L1MUT</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector <break/>that expresses human CD95L <break/>cDNA (NM_000639.2) with 8 <break/>silentmutations overlapping <break/>the shL1 target site <break/>(GCATCATCTTTGGAGAAGCAA <break/>-&#160;&gt;&#160;GCCTCGTCCCTAGAAAAACAG); used <break/>to express shL1-resistant human <break/>CD95L upon infection <break/>with lentiviral particles</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pLenti-CD95L- <break/>L3MUT</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector <break/>that expresses human CD95L <break/>cDNA (NM_000639.2) with 8 silent <break/>mutations overlapping the shL3 <break/>target site <break/>(ACTGGGCTGTACTTTGTATAT <break/>-&#160;&gt;&#160;ACCGGATTATATTTCGTGTAC); <break/>used to express shL3-resistant <break/>human CD95L upon infection <break/>with lentiviral particles</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pLNCX2-CD95-WT</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLNCX2 vector that expresses <break/>human CD95 cDNA (BC012479.1); <break/>used to express wild type CD95 <break/>upon infection with lentiviral particles</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">pLNCX2-CD95-R6MUT</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLNCX2 vector that expresses mutant <break/>human CD95 cDNA (BC012479.1) which <break/>contains 8 silent mutations <break/>overlapping the shR6 site <break/>(GTGTCGCTGTAAACCAAACTT <break/>-&#160;&gt;&#160;ATGTCGCTGCAAGCCCAATTT); <break/>used to express shR6-resistant <break/>CD95 upon infection with <break/>lentiviral particles</td></tr><tr><td valign="top">Transfected construct</td><td valign="top">gRNA scaffold</td><td valign="top">PMID: 23287722</td><td valign="top">IDT: synthesized <break/>as gene block</td><td valign="top">455 nucleotide CRISPR/Cas9 <break/>gRNA scaffold synthesized as a <break/>gene block; contains promoter, <break/>gRNA scaffold, target sequence, <break/>and termination sequence; scaffold <break/>transcribes gRNAs that target Cas9 <break/>endonuclease to cut at target sites; <break/>target sequences consist of 19 <break/>nucleotides that are complementary to <break/>the target site of choice; co-transfected <break/>with Cas9 to catalyze cleavage.</td></tr><tr><td valign="top">Transfected construct</td><td valign="top">pMJ920 Cas9 plasmid</td><td valign="top">Addgene; <break/>PMID: 23386978</td><td valign="top">Addgene: cat#42234</td><td valign="top">Plasmid that expresses a human <break/>codon-optimized Cas9 tagged with <break/>GFP and HA; used to express Cas9 for <break/>CRISPR-mediated deletions.</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">Lipofectamine 2000</td><td valign="top">ThermoFisher Scientific</td><td valign="top">ThermoFisher Scientific: <break/>cat#11668019</td><td valign="top">Transfection reagent</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">Lipofectamine RNAiMAX</td><td valign="top">ThermoFisher Scientific</td><td valign="top">ThermoFisher Scientific: <break/>cat#13778150</td><td valign="top">Transfection reagent; used for <break/>transfection of small RNAs such as siRNAs</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">StrataClone Blunt <break/>PCR Cloning Kit</td><td valign="top">Agilent Technologies</td><td valign="top">Agilent Technologies: <break/>cat#240207</td><td valign="top">Used to blunt-end clone the gRNA <break/>scaffolds into the pSC-B plasmid</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">High-Capacity cDNA <break/>reverse transcription kit</td><td valign="top">Applied Biosystems</td><td valign="top">4368814</td><td valign="top"/></tr><tr><td valign="top">Array cards preloaded <break/>with primers</td><td valign="top">384-well TLDA cards</td><td valign="top">Applied Biosystems</td><td valign="top">43422489</td><td valign="top"/></tr><tr><td valign="top">Commercial&#160;assay&#160;kit&#160;</td><td valign="top">Taqman Gene <break/>expression master mix</td><td valign="top">ThermoFisher Scientific</td><td valign="top">4369016</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shL3 flanking Fr primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Fr primer that flanks shL3 site; <break/>used to detect 41 nt shL3 deletion; <break/>5&#8217;-TCTGGAATGGGAAGACACCT-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shL3 flanking Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Rev primer that flanks shL3 site; <break/>used to detect 41 nt shL3 deletion; <break/>5&#8217;-CCTCCATCATCACCAGATCC-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shL3 internal Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Rev primer that overlaps with the shL3 site; <break/>used to detect 41 nt shL3 deletion; <break/>5&#8217;-ATATACAAAGTACAGCCCAGT-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shR6 flanking Fr primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Fr primer that flanks shR6 site; <break/>used to detect 227 nt shR6 deletion; <break/>5&#8217;-GGTGTCATGCTGTGACTGTTG-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shR6 flanking Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Rev primer that flanks shR6 site; <break/>used to detect 227 nt shR6 deletion; <break/>5&#8217;-TTTAGCTTAAGTGGCCAGCAA-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shR6 internal Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Rev primer that overlaps with the shR6 site; <break/>used to detect 227 nt shR6 deletion; <break/>5&#8217;-AAGTTGGTTTACATCTGCAC-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL3 flanking Fr primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Fr primer that flanks siL3 site; <break/>used to detect 64 nt siL3 deletion; <break/>5&#8217;-CTTGAGCAGTCAGCAACAGG-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL3 flanking Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Rev primer that flanks siL3 site; <break/>used to detect 64 nt siL3 deletion; <break/>5&#8217;-CAGAGGTTGGACAGGGAAGA-3&#8217;</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL3 internal Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom DNA oligo</td><td valign="top">Rev primer that is internal to the siL3 site; <break/>used to detect 64 nt siL3 deletion; <break/>5&#8217;-ATATGGGTAATTGAAGGGCTG-3&#8217;.</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siScr</td><td valign="top">IDT; Dharmacon</td><td valign="top">Dharmacon <break/>#D-001810-02-05</td><td valign="top">sense: UGGUUUACAUGUUGUGUGA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL1</td><td valign="top">Dharmacon</td><td valign="top">L-011130-00-0005</td><td valign="top">sense: UACCAGUGCUGAUCAUUUA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL1</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: UACCAGUGCUGAUCAUUUA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL2</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: CAACGUAUCUGAGCUCUCU</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL3</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: GCCCUUCAAUUACCCAUAU</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL3MUT</td><td valign="top">IDT</td><td valign="top">IDT #51-01-14-03</td><td valign="top">sense: GGACUUCAACUAGACAUCU</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siL4</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: GGAAAGUGGCCCAUUUAAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shL3&#160;=&gt;&#160;siL3</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: GACUGGGCUGU <break/>ACUUUGUAdTdA <break/>antisense: UACAAAGUACA <break/>GCCCAGUUdTdT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">shR6&#160;=&gt;&#160;siR6</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: GGGUGCAGAU <break/>GUAAACCAAAdCdT; <break/>antisense: UUUGGUUUACA <break/>UCUGCACUUdTdT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dsi-13.2</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: AUCUU ACCAGUGC <break/>UGAUCAUUUAdTdA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dsi-13.3</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: AAAGUAUACUU <break/>CCGGGGUCAAUCdTdT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dsi-13.9</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: CUUCCGGGG <break/>UCAAUCUUGCAACAdAdC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dsi-13.x</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: CAGGACUGAGAAG <break/>AAGUAAAACCdGdT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">DsiL3</td><td valign="top">IDT</td><td valign="top">customer synthesis</td><td valign="top">sense: CAGCCCUUCAAU <break/>UACCCAUAUCCdCdC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">siScr pool</td><td valign="top">Dharmacon</td><td valign="top">D-001810&#8211;10</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting NUCKS1</td><td valign="top">Dharmacon</td><td valign="top">L-014208&#8211;02</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting CAPZA1</td><td valign="top">Dharmacon</td><td valign="top">L-012212&#8211;00</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting CCT3</td><td valign="top">Dharmacon</td><td valign="top">L-018339&#8211;00</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting FSTL1</td><td valign="top">Dharmacon</td><td valign="top">L-013615&#8211;00</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting FUBP1</td><td valign="top">Dharmacon</td><td valign="top">L-011548&#8211;00</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting GNB1</td><td valign="top">Dharmacon</td><td valign="top">L-017242&#8211;00</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting NAA50</td><td valign="top">Dharmacon</td><td valign="top">L-014597&#8211;01</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting PRELID3B</td><td valign="top">Dharmacon</td><td valign="top">L-020893&#8211;01</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting SNRPE</td><td valign="top">Dharmacon</td><td valign="top">L-019719&#8211;02</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting TFRC</td><td valign="top">Dharmacon</td><td valign="top">L-003941&#8211;00</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">smartpool siRNA <break/>targeting HIST1H1C</td><td valign="top">Dharmacon</td><td valign="top">L-006630&#8211;00</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">GAPDH primer</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00266705_g1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">CD95 primer</td><td valign="top">Thermofisher Scientific</td><td valign="top">custom probe</td><td valign="top">Fr primer: GGCTAACCCC <break/>ACTCTATGAATCAAT <break/>Rev primer: GGCCTGCCT <break/>GTTCAGTAACT <break/>Probe: CCTT <break/>TTGCTGAAATATC</td></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">CD95 primer <break/>(<xref ref-type="fig" rid="fig5s3">Figure 5&#8212;figure supplement 3</xref>)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00163653_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">CD95L primers</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00181226_g1; <break/>Hs00181225_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">shL3 target <break/>site in CD95L</td><td valign="top">Thermofisher Scientific</td><td valign="top">custom probe</td><td valign="top">Fr primer: <italic>GGTGGCC</italic> <break/><italic>TTGTGATCAATGAAA</italic> <break/>Rev primer: <italic>GCAAGA</italic> <break/><italic>TTGACCCCGGAAGTATA</italic> <break/>Probe: <italic>CTG</italic> <break/><italic>GGCTGTACTTTGTATATT</italic></td></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">downstream of shL3 site</td><td valign="top">Thermofisher Scientific</td><td valign="top">custom probe</td><td valign="top">Fr primer: <italic>CCCC</italic> <break/><italic>AGGATCTGGTGATGATG</italic> <break/>Rev primer: <italic>ACTG</italic> <break/><italic>CCCCCAGGTAGCT</italic> <break/>Probe: <italic>CCCAC</italic> <break/><italic>ATCTGCCCAGTAGT</italic></td></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">GAPDH primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs99999905_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">ATP13A3 primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00225950_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">CAPZA1 primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00855355_g1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">CCT3 primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00195623_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">FSTL1 primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00907496_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">FUPB1 primer ( <break/>TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00900762_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">GNB1 primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00929799_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">HIST1H1C <break/>primer (TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00271185_s1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">NAA50 primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00363889_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">NUCKS1 primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs01068059_g1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">PRELID3B primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00429845_m1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">SNRPE primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs01635040_s1</td><td valign="top"/></tr><tr><td valign="top">Sequence based reagent <break/>(human)</td><td valign="top">TFRC primer <break/>(TLDA card)</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00951083_m1</td><td valign="top"/></tr><tr><td valign="top">Software</td><td valign="top">Stata 14</td><td valign="top">Stata</td><td valign="top"/><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_012763">SCR_012763</ext-link></td></tr><tr><td valign="top">Software</td><td valign="top">Rstudio (R3.3.1)</td><td valign="top">Rstudio</td><td valign="top"/><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_000432">SCR_000432</ext-link></td></tr><tr><td valign="top">sequence based reagent</td><td valign="top">shScr</td><td valign="top">Sigma</td><td valign="top">SHC002V</td><td valign="top">Non-targeting shRNA <break/>control transduction particles</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL1</td><td valign="top">Sigma</td><td valign="top">TRCN0000058998</td><td valign="top">GCATCATCTTTGGAGAAGCAA</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL2</td><td valign="top">Sigma</td><td valign="top">TRCN0000058999</td><td valign="top">CCCATTTAACAGGCAAGTCCA</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL3</td><td valign="top">Sigma</td><td valign="top">TRCN0000059000</td><td valign="top">ACTGGGCTGTACTTTGTATAT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL4</td><td valign="top">Sigma</td><td valign="top">TRCN0000059001</td><td valign="top">GCAGTGTTCAATCTTACCAGT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL5</td><td valign="top">Sigma</td><td valign="top">TRCN0000059002</td><td valign="top">CTGTGTCTCCTTGTGATGTTT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL6</td><td valign="top">Sigma</td><td valign="top">TRCN0000372231</td><td valign="top">TGAGCTCTCTCTGGTCAATTT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL2'</td><td valign="top">Sigma</td><td valign="top">TRCN0000372232</td><td valign="top">TAGCTCCTCAACTCACCTAAT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shL5'</td><td valign="top">Sigma</td><td valign="top">TRCN0000372175</td><td valign="top">GACTAGAGGCTTGCATAATAA</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR2</td><td valign="top">Sigma</td><td valign="top">TRCN0000218492</td><td valign="top">CTATCATCCTCAAGGACATTA</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR5</td><td valign="top">Sigma</td><td valign="top">TRCN0000038695</td><td valign="top">GTTGCTAGATTATCGTCCAAA</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR6</td><td valign="top">Sigma</td><td valign="top">TRCN0000038696</td><td valign="top">GTGCAGATGTAAACCAAACTT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR7</td><td valign="top">Sigma</td><td valign="top">TRCN0000038697</td><td valign="top">CCTGAAACAGTGGCAATAAAT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR8</td><td valign="top">Sigma</td><td valign="top">TRCN0000038698</td><td valign="top">GCAAAGAGGAAGGATCCAGAT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR27'</td><td valign="top">Sigma</td><td valign="top">TRCN0000265627</td><td valign="top">TTTTACTGGGTACATTTTATC</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR7'</td><td valign="top">Sigma</td><td valign="top">TRCN0000255407</td><td valign="top">TTAAATTATAATGTTTGACTA</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR8'</td><td valign="top">Sigma</td><td valign="top">TRCN0000255408</td><td valign="top">ATATCTTTGAAAGTTTGTATT</td></tr><tr><td valign="top">sequence based reagent <break/>(human)</td><td valign="top">shR6'</td><td valign="top">Sigma</td><td valign="top">TRCN0000255406</td><td valign="top">CCCTTGTGTTTGGAATTATAA</td></tr></tbody></table></table-wrap>